RecruitingNot ApplicableNCT06497283

Binaural Sound for Remimazolam Maintenance

The Effect of Intraoperative Binaural Sound on Remifentanil Dose Required for General Anesthesia Using Remimazolam: a Randomized, Placebo-controlled Trial


Sponsor

Gangnam Severance Hospital

Enrollment

72 participants

Start Date

Jul 12, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

It is important to decrease the remifentanil dose for general anesthesia maintenance when using remimazolam. We will evaluate the effect of binaural sound on general anesthesia maintenance with remimazolam infusion.


Eligibility

Min Age: 20 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether playing binaural beats (a type of sound therapy through headphones) during general anesthesia can reduce how much of the sedative drug remimazolam patients need during surgery. **You may be eligible if...** - You are between 20 and 60 years old and scheduled for surgery requiring general anesthesia - Your general health is relatively good (ASA classification 1 or 2, meaning no major systemic illness) - Your ideal body weight is between 50 and 80 kg **You may NOT be eligible if...** - You have a hearing disability - You have used opioids or sedatives in the past week - You are dependent on alcohol or drugs - You are allergic to remimazolam or remifentanil - You have heart rhythm problems (arrhythmia) or cardiovascular disease Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREBinaural sound

Binaural sound: Binaural sound will be applied.


Locations(1)

Gangnam Severance Hospital

Seoul, South Korea

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06497283


Related Trials